B. Qin

发表

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.

Li Huang, Chin-Ho Chen, Keduo Qian, 2012, Bioorganic & medicinal chemistry letters.

Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.

Hong Lu, Shibo Jiang, Li Huang, 2010, Journal of medicinal chemistry.

MAVS O-GlcNAcylation Is Essential for Host Antiviral Immunity against Lethal RNA Viruses.

F. Liu, Lei Zhao, Hui-Yan Li, 2019, Cell reports.

A nanoparticle-encapsulated non-nucleoside reverse-transcriptase inhibitor with enhanced anti-HIV-1 activity and prolonged circulation time in plasma.

Q. Wang, Lu Lu, Shibo Jiang, 2014, Current pharmaceutical design.

Integrating concept of pharmacophore with graph neural networks for chemical property prediction and interpretation

R. Liu, A. Yan, Y. Kong, 2022, Journal of Cheminformatics.

Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Hong Lu, Shibo Jiang, Chin-Ho Chen, 2009, Bioorganic & medicinal chemistry letters.

Notch activation enhances microglial CX3CR1/P38 MAPK pathway in rats model of vincristine-induced peripheral neuropathy

B. Qin, Weihong Zheng, Yuxing Li, 2019, Neuroscience Letters.

[Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].

Hong Lu, Shibo Jiang, Ting Zhou, 2009, Yao xue xue bao = Acta pharmaceutica Sinica.

Optimization of N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines as tubulin polymerization inhibitors.

Xiao‐Feng Wang, K. Lee, S. Morris-Natschke, 2015, Bioorganic & medicinal chemistry.

Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus.

Weifan Zheng, Shibo Jiang, Na Liu, 2016, Journal of medicinal chemistry.

Protective effect of gastrodin on peripheral neuropathy induced by anti-tumor treatment with vincristine in rat models

Xiao Tan, Jun Zheng, B. Qin, 2021, Drug and chemical toxicology.

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.

Bingjie Qin, Lan Xie, Li Huang, 2012, Journal of medicinal chemistry.

Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus

Qi Chen, Huan Zhou, Qisheng Wang, 2021, Journal of virology.

Design and synthesis of diarylamines and diarylethers as cytotoxic antitumor agents.

W. Janzen, M. Hour, Xiao‐Feng Wang, 2012, Bioorganic & medicinal chemistry letters.

Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Lu Lu, Bingjie Qin, Lan Xie, 2014, Bioorganic & medicinal chemistry letters.

Optimization of the Antiviral Potency and Lipophilicity of Halogenated 2,6‐Diarylpyridinamines as a Novel Class of HIV‐1 NNRTIS

Bingjie Qin, Lan Xie, Shibo Jiang, 2014, ChemMedChem.

Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Hong Lu, Shibo Jiang, Xiao‐Feng Wang, 2010, Journal of medicinal chemistry.

Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.

Hong Lu, Shibo Jiang, Li Huang, 2010, Journal of medicinal chemistry.

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.

Li Huang, Chin-Ho Chen, Keduo Qian, 2012, Bioorganic & medicinal chemistry letters.

Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Hong Lu, Shibo Jiang, Xiao‐Feng Wang, 2010, Journal of medicinal chemistry.